AAAAAA

   
Results: 1-25 | 26-49
Results: 1-25/49
Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART
Authors: Monforte, AD Bugarini, R Pezzotti, P De Luca, A Antinori, A Mussini, C Vigevani, GM Tirelli, U Bruno, R Gritti, F Piazza, M Chigiotti, S Chirianni, A De Stefano, C Pizzigallo, E Perrella, O Moroni, M
Citation: Ad. Monforte et al., Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART, J ACQ IMM D, 28(2), 2001, pp. 114-123
Incidence of invasive cervical cancer in a cohort of HIV-seropositive women before and after the introduction of highly active antiretroviral therapy
Authors: Dorrucci, M Suligoi, B Serraino, D Tirelli, U Rezza, G
Citation: M. Dorrucci et al., Incidence of invasive cervical cancer in a cohort of HIV-seropositive women before and after the introduction of highly active antiretroviral therapy, J ACQ IMM D, 26(4), 2001, pp. 377-380
Chronic hepatitis C in HIV-coinfected patients: Feasibility and efficacy of interferon-alpha 2b and ribavirin combination therapy
Authors: Nasti, G di Gennaro, G Rizzardini, G Cadorin, L Tirelli, U
Citation: G. Nasti et al., Chronic hepatitis C in HIV-coinfected patients: Feasibility and efficacy of interferon-alpha 2b and ribavirin combination therapy, J ACQ IMM D, 26(3), 2001, pp. 299-300
Discordant HHV8 detection in a young HIV-negative patient with Kaposi's sarcoma and sarcoidosis
Authors: di Gennaro, G Canzonieri, V Schioppa, O Nasti, G Carbone, A Tirelli, U
Citation: G. Di Gennaro et al., Discordant HHV8 detection in a young HIV-negative patient with Kaposi's sarcoma and sarcoidosis, CLIN INF D, 32(7), 2001, pp. 1100-1102
Management of hematologic malignancies in the elderly: 15-year experience at the Aviano Cancer Center, Italy
Authors: Zagonel, V Monfardini, S Tirelli, U Carone, A Pinto, A
Citation: V. Zagonel et al., Management of hematologic malignancies in the elderly: 15-year experience at the Aviano Cancer Center, Italy, CR R ONC H, 39(3), 2001, pp. 289-305
A 20-year experience on malignant lymphomas in patients aged 70 and older at a single institute
Authors: Tirelli, U Carbone, A Monfardini, S Zagonel, V
Citation: U. Tirelli et al., A 20-year experience on malignant lymphomas in patients aged 70 and older at a single institute, CR R ONC H, 37(2), 2001, pp. 153-158
Clinical aspects and management of Hodgkin's disease and other tumours in HIV-infected individuals
Authors: Vaccher, E Spina, M Tirelli, U
Citation: E. Vaccher et al., Clinical aspects and management of Hodgkin's disease and other tumours in HIV-infected individuals, EUR J CANC, 37(10), 2001, pp. 1306-1315
Impact of HAART on the clinical management of AIDS-related cancers
Authors: Tirelli, U Bernardi, D
Citation: U. Tirelli et D. Bernardi, Impact of HAART on the clinical management of AIDS-related cancers, EUR J CANC, 37(10), 2001, pp. 1320-1324
Lymphocyte subsets and viral load in patients with HIV-associated non-Hodgkin's lymphoma treated with anti-CD20 monoclonal antibody and chemotherapy
Authors: De Paoli, P Vaccher, E Tedeschi, R Caffau, C Zanussi, S Bortolin, MT Crepaldi, C Spina, M Tirelli, U
Citation: P. De Paoli et al., Lymphocyte subsets and viral load in patients with HIV-associated non-Hodgkin's lymphoma treated with anti-CD20 monoclonal antibody and chemotherapy, CANCER IMMU, 50(3), 2001, pp. 157-162
Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin
Authors: Nasti, G Di Gennaro, G Tavio, M Cadorin, L Tedeschi, RM Talamini, R Carbone, A Tirelli, U
Citation: G. Nasti et al., Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin, AIDS, 15(14), 2001, pp. 1783-1787
Human immunodeficiency virus-related non-Hodgkin lymphoma - Activity of infusional cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40 patients
Authors: Spina, M Vaccher, E Juzbasic, S Milan, I Nasti, G Talamini, R Fasan, M Antinori, A Nigra, E Tirelli, U
Citation: M. Spina et al., Human immunodeficiency virus-related non-Hodgkin lymphoma - Activity of infusional cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40 patients, CANCER, 92(1), 2001, pp. 200-206
Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma
Authors: Vaccher, E Spina, M di Gennaro, G Talamini, R Nasti, G Schioppa, O Vultaggio, G Tirelli, U
Citation: E. Vaccher et al., Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma, CANC CYTOP, 91(1), 2001, pp. 155-163
Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma
Authors: Vaccher, E Spina, M di Gennaro, G Talamini, R Nasti, G Schioppa, O Vultaggio, G Tirelli, U
Citation: E. Vaccher et al., Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma, CANCER, 91(1), 2001, pp. 155-163
Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novelhistogenetic subsets of human immunodeficiency virus-related lymphomas
Authors: Carbone, A Gloghini, A Larocca, LM Capello, D Pierconti, F Canzonieri, V Tirelli, U Dalla-Favera, R Gaidano, G
Citation: A. Carbone et al., Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novelhistogenetic subsets of human immunodeficiency virus-related lymphomas, BLOOD, 97(3), 2001, pp. 744-751
Hodgkin's disease: Clinical presentation and treatment
Authors: Tirelli, U Vaccher, E Spina, M Carbone, A
Citation: U. Tirelli et al., Hodgkin's disease: Clinical presentation and treatment, CANC TREAT, 104, 2001, pp. 247-265
Effects of 2-year antiretroviral combination therapies on HIV-1 DNA levels
Authors: Zanussi, S Bortolin, MT Tirelli, U Nasti, G Vaccher, E Giacca, M De Paoli, P
Citation: S. Zanussi et al., Effects of 2-year antiretroviral combination therapies on HIV-1 DNA levels, J ACQ IMM D, 23(5), 2000, pp. 439-441
Mutation of BAX occurs infrequently in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas
Authors: Gaidano, G Vivenza, D Forconi, F Capello, D Gloghini, A Bhatia, K Gutierrez, M Gallicchio, M Avanzi, GC Fassone, L Ariatti, C Buonaiuto, D Cingolani, A Saglio, G Tirelli, U Larocca, LM Dalla-Favera, R Carbone, A
Citation: G. Gaidano et al., Mutation of BAX occurs infrequently in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas, GENE CHROM, 27(2), 2000, pp. 177-182
Primary effusion lymphoma cell lines harbouring human herpesvirus type-8
Authors: Carbone, A Cilia, AM Gloghini, A Capello, D Perin, T Bontempo, D Canzonieri, V Tirelli, U Volpe, R Gaidano, G
Citation: A. Carbone et al., Primary effusion lymphoma cell lines harbouring human herpesvirus type-8, LEUK LYMPH, 36(5-6), 2000, pp. 447-456
Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma
Authors: Carbone, A Cilia, AM Gloghini, A Capello, D Fassone, L Perin, T Rossi, D Canzonieri, V De Paoli, P Vaccher, E Tirelli, U Volpe, R Gaidano, G
Citation: A. Carbone et al., Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma, LEUKEMIA, 14(7), 2000, pp. 1301-1309
Molecular profile of Epstein-Barr virus infection in HHV-8-positive primary effusion lymphoma
Authors: Fassone, L Bhatia, K Gutierrez, M Capello, D Gloghini, A Dolcetti, R Vivenza, D Ascoli, V Lo Coco, F Pagani, L Dotti, G Rambaldi, A Raphael, M Tirelli, U Saglio, G Magrath, IT Carbone, A Gaidano, G
Citation: L. Fassone et al., Molecular profile of Epstein-Barr virus infection in HHV-8-positive primary effusion lymphoma, LEUKEMIA, 14(2), 2000, pp. 271-277
Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: Results of a phase II study
Authors: Nasti, G Errante, D Talamini, R Rizzardini, G Fasan, M Landonio, G Zeroli, C Chichino, G Nigra, E Vaccher, E Tirelli, U
Citation: G. Nasti et al., Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: Results of a phase II study, J CL ONCOL, 18(7), 2000, pp. 1550-1557
Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients
Authors: Monforte, AD Lepri, AC Rezza, G Pezzotti, P Antinori, A Phillips, AN Angarano, G Colangeli, V De Luca, A Ippolito, G Caggese, L Soscia, F Filice, G Gritti, F Narciso, P Tirelli, U Moroni, M
Citation: Ad. Monforte et al., Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients, AIDS, 14(5), 2000, pp. 499-507
Epidemiological, biological and clinical features of HIV-related lymphomasin the era of highly active antiretroviral therapy
Authors: Tirelli, U Spina, M Gaidano, G Vaccher, E Franceschi, S Carbone, A
Citation: U. Tirelli et al., Epidemiological, biological and clinical features of HIV-related lymphomasin the era of highly active antiretroviral therapy, AIDS, 14(12), 2000, pp. 1675-1688
Stanford V regimen and concomitant highly active antiretroviral therapy isfeasible and active in patients with Hodgkin's disease and HIV infection
Authors: Spina, M Gabarre, J Fasan, M Vaccher, E Tirelli, U
Citation: M. Spina et al., Stanford V regimen and concomitant highly active antiretroviral therapy isfeasible and active in patients with Hodgkin's disease and HIV infection, AIDS, 14(10), 2000, pp. 1457-1458
Human immunodeficiency virus-associated Hodgkin's disease
Authors: Spina, M Vaccher, E Nasti, G Tirelli, U
Citation: M. Spina et al., Human immunodeficiency virus-associated Hodgkin's disease, SEMIN ONCOL, 27(4), 2000, pp. 480-488
Risultati: 1-25 | 26-49